iMDx Announces Participation in NYC Investment Conferences
ByAinvest
Tuesday, Aug 26, 2025 4:08 pm ET1min read
IMDX--
The H.C. Wainwright event will be held both in-person at the Lotte New York Palace Hotel and virtually. Investors can register through H.C. Wainwright sales representatives. The Lake Street Capital Markets conference will be held in-person at the Yale Club of New York City. Investors are encouraged to reach out to their Lake Street sales representatives for more information.
iMDx's mission is to democratize access to novel molecular diagnostic testing to improve patient outcomes. The company has a portfolio of products including GraftAssureCore™, GraftAssureIQ™, GraftAssureDx™, VitaGraft™, GraftAssure™, DetermaIO™, and DetermaCNI™. Investors interested in learning more can visit the company's investor website at https://investors.Insight Molecular Diagnostics.com/.
References:
[1] https://www.stocktitan.net/news/IMDX/i-m-dx-to-participate-in-nyc-investment-conferences-september-8-b8wtomqv008y.html
iMDx, a molecular diagnostics company, announced participation in two investor conferences: H.C. Wainwright's 27th Annual Global Investment Conference and Lake Street Capital Markets' 9th Annual Best Ideas Growth Conference. The company will present a live presentation on September 8 and hold one-on-one meetings at both events. Investors can register through H.C. Wainwright or Lake Street sales representatives. iMDx aims to improve patient outcomes through novel molecular diagnostic testing.
Insight Molecular Diagnostics Inc., or iMDx (NASDAQ: IMDX), has announced its participation in two upcoming investor conferences in New York City. The company will present at the H.C. Wainwright 27th Annual Global Investment Conference on September 8-9, 2025, featuring a company presentation on September 8 at 5:00 pm ET, along with one-on-one meetings. Additionally, iMDx will participate in the Lake Street Capital Markets 9th Annual Best Ideas Growth Conference on September 11, 2025, which will consist of one-on-one meetings with investors at the Yale Club of New York City.The H.C. Wainwright event will be held both in-person at the Lotte New York Palace Hotel and virtually. Investors can register through H.C. Wainwright sales representatives. The Lake Street Capital Markets conference will be held in-person at the Yale Club of New York City. Investors are encouraged to reach out to their Lake Street sales representatives for more information.
iMDx's mission is to democratize access to novel molecular diagnostic testing to improve patient outcomes. The company has a portfolio of products including GraftAssureCore™, GraftAssureIQ™, GraftAssureDx™, VitaGraft™, GraftAssure™, DetermaIO™, and DetermaCNI™. Investors interested in learning more can visit the company's investor website at https://investors.Insight Molecular Diagnostics.com/.
References:
[1] https://www.stocktitan.net/news/IMDX/i-m-dx-to-participate-in-nyc-investment-conferences-september-8-b8wtomqv008y.html

Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue

Comments
No comments yet